Patents Examined by Sean P Dougherty
  • Patent number: 11523757
    Abstract: An electrochemical sensor including a working electrode having an arrangement of pillars defining channels between the pillars. The channels increase confinement of a byproduct produced in an electrochemical reaction used during sensing of an analyte, so as to increase interaction of the byproduct with the working electrode. A number of working embodiments of the invention are shown to be useful in amperometric glucose sensors worn by diabetic individuals.
    Type: Grant
    Filed: August 1, 2019
    Date of Patent: December 13, 2022
    Assignee: MEDTRONIC MINIMED, INC.
    Inventors: Zhenzhong Sun, Xin Heng, Rui Kong
  • Patent number: 11523746
    Abstract: Various aspects of the present disclosure are directed toward apparatuses, systems, and methods for supporting components of an implantable medical device. The apparatuses, systems, and methods may include a first electrode and a second electrode and a scaffold assembly configured to support the first electrode and the second electrode.
    Type: Grant
    Filed: October 28, 2019
    Date of Patent: December 13, 2022
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Ron A. Balczewski, Jean M. Bobgan, Aleksandra Kharam, David P. Stieper, Scott R. Vanderlinde
  • Patent number: 11517295
    Abstract: Methods and devices for performing minimally invasive procedures useful for Fallopian tube diagnostics are disclosed. In at least one embodiment, the proximal os of the Fallopian tube is accessed via an intrauterine approach; an introducer catheter is advanced to cannulate and form a fluid tight seal with the proximal os of the Fallopian tube; a second catheter inside the introducer catheter is provided to track the length of the Fallopian tube and out into the abdominal cavity; a balloon at the end of the second catheter is inflated and the second catheter is retracted until the balloon seals the distal os of the Fallopian tube; irrigation is performed substantially over the length of the Fallopian tube; and the irrigation fluid is recovered for cytology or cell analysis.
    Type: Grant
    Filed: March 30, 2020
    Date of Patent: December 6, 2022
    Assignee: BOSTON SCIENTIFIC SCIMED, INC.
    Inventors: Albert Chin, Surbhi Sarna, David W. Snow, Jesus Magana
  • Patent number: 11517220
    Abstract: Systems, devices, and methods are disclosed for the purpose of quantitatively determining the susceptibility of a human subject to injure their Anterior Cruciate Ligament (ACL). A method for determining injury susceptibility scores or risk categories includes determining hip extension angles and knee varus angles during the performance of a stork test and determining hip abduction angles during a squat test. Determination of angles during certain movements may be achieved using various systems and devices, including wearable devices.
    Type: Grant
    Filed: April 2, 2019
    Date of Patent: December 6, 2022
    Inventor: Lindsey Chavey
  • Patent number: 11517209
    Abstract: Pressure sensing guidewire assemblies are described herein where the guidewire assembly may be comprised of an elongate guidewire body and multiple pressure sensors secured near or at a distal end of the guidewire body. The signals obtained from the guidewire connectors and aortic sensor modules may be synchronized to minimize signal acquisition delays. The signals may be further processed to equalize the pressure waveforms by shifting the connector waveform to align correctly with the aortic module waveform and improve output signals.
    Type: Grant
    Filed: January 9, 2019
    Date of Patent: December 6, 2022
    Assignee: PATHWAYS MEDICAL CORPORATION
    Inventors: Goutam Dutta, Nitin Patil
  • Patent number: 11510624
    Abstract: A method of determining one or more vital sign parameters by a wireless vital-sign measurement device comprises: measuring motion information of a user wearing the wireless measurement device, the measurement device being in the idle mode in which at least one opto-electronic sensor in the measurement device is deactivated; switching the measurement device in an active mode if the motion information is below a predetermined threshold, wherein in the active mode the at least one opto-electronic sensor is activated; during a predetermined measuring period, exposing part of a skin tissue of the user to light and measuring one or more optical response signals associated with the exposed skin tissue and the motion sensor measuring motion information associated with movements of the user; and, selecting or rejecting one or more pulses in the one or more optical response signals on the basis of the motion information measured during the measuring period and determining one or more vital sign parameters on the basis
    Type: Grant
    Filed: September 27, 2017
    Date of Patent: November 29, 2022
    Inventors: Stefanus Hendrikus Hubertina Grassere, Joris Christian Beudel, Maarten-Jan Van Fulpen
  • Patent number: 11510661
    Abstract: A full core biopsy device includes a needle assembly having stylet, spoon, and at least one coring cannula. A window is located in at least one of the spoon and coring cannula. A excising finger is configured to prolapse through the window into a lumen of the inner spoon or cannula to sever a tissue sample upon translation or axial advancement of the excising finger.
    Type: Grant
    Filed: January 31, 2019
    Date of Patent: November 29, 2022
    Assignee: RLS Interventional, Inc.
    Inventors: Steven E. Field, Chad J. Bacon
  • Patent number: 11504013
    Abstract: A monitoring system configured to measure the user's health-related parameters while in a certain state is disclosed. Based on whether the user is in the certain state and/or one or more criteria being met, the monitoring system can perform a physiological measurement such as a blood pressure measurement. The monitoring system can be capable of dynamically adjusting the measurement parameters, criteria, and acquired information based one or more scalers. The criteria can be based on user states or conditions such that user disruptions can be reduced and the measurement accuracy and/or efficiency can be enhanced. The monitoring system can also measure the user's parameters during the measurement and may abort the measurement if the measurement may not have accurate information and/or to reduce any disruption to the user. Alternatively, the measurement can be annotated so that the measurement can be used during data interpretation with certain qualifiers attached.
    Type: Grant
    Filed: June 12, 2019
    Date of Patent: November 22, 2022
    Assignee: Apple Inc.
    Inventors: Derek Young, Alexander M. Chan, German A. Alvarez, Joseph R. Lee, Manda Paul, Santiago M. Quijano
  • Patent number: 11497442
    Abstract: A method for assessing and reversing exercise impairment in adults having peripheral vascular disease includes quantifying a musculoskeletal deoxygenation level (MDL) of a human subject provided by a wearable near infrared spectroscopy system configured to measure the deoxygenation level during exercise, comparing the quantified MDL to a range of pre-determined healthy MDL values for the subject, and, if the quantified MDL is outside of the pre-determined target MDL values, determining a corrective exercise intensity level or ‘dose’ effective to bring the MDL of the subject within the target MDL values and reverse the exercise impairment.
    Type: Grant
    Filed: November 10, 2021
    Date of Patent: November 15, 2022
    Assignee: EDEN MEDICAL, INC.
    Inventor: Jeffrey Norman Schoess
  • Patent number: 11497450
    Abstract: An adaptive noise quantification system and associated methods are disclosed for use in the dynamic biosignal analysis of a user. In at least one embodiment, the system includes a biosignal sensor positioned and configured for obtaining and transmitting data related to a select at least one vital of the user as a biosignal, and a motion sensor positioned and configured for obtaining and transmitting data related to a motion level of the user as a motion signal. A computing device is configured for receiving and processing the biosignal and motion signal.
    Type: Grant
    Filed: February 4, 2020
    Date of Patent: November 15, 2022
    Assignee: Smart Solutions Technologies, S.L.
    Inventors: Agustín Maciá Barber, Xavier Ibáñez Català
  • Patent number: 11497452
    Abstract: The present disclosure describes a system, method and software applications for predicting the KAM of a subject for a plurality of gait cycles of a subject. At least one sensor attachable adjacent to the ankle of at least one leg of the subject provides accelerometer and gyroscopic data for the plurality of gait cycles. A processing means receives subject parameters and accelerometer and gyroscopic data from the at least one sensor for evaluation by a neural network of predicted KAM values for the plurality of gait cycles of the subject. The neural network is configured via determining KAM values for each of the plurality of subjects from measurements during a plurality of gait cycles and other parameters.
    Type: Grant
    Filed: June 20, 2019
    Date of Patent: November 15, 2022
    Assignee: The Hong Kong Polytechnic University
    Inventors: Tsz Hei Cheung, Ho Man Chan, Kevin Ki Wai Ho, Zoe Yau Shan Chan, Hanwen Zhang, Man Fung Lam, Chao Wang, Sizhong Wang, Shuotong Wang, Xiaoyu Wei, Akash Malhotra, Chun Kwan Ching
  • Patent number: 11490844
    Abstract: A catheter for measuring pressure in the urinary tract of a patient includes a catheter body having a proximal and distal end. A plurality of lumens is formed in the catheter body, and an adaptor is coupled to the proximal end of the catheter body. The adaptor includes a port for each lumen. A first pressure sensor, typically including a balloon, is fluidically coupled to a first lumen and is configured and positioned to measure pressure in a urethra of the patient. A second pressure sensor, also typically including a balloon, is fluidically coupled to a second lumen and is configured and positioned on the catheter body to measure pressure in a bladder of the patient. An expandable retention member, which may be coupled to a third lumen, is positioned on the catheter body between the first and second expandable pressure sensors so that the catheter body may be retained at a selected location in the urinary tract to properly position the fluid pressure sensors in the bladder and urethra, respectively.
    Type: Grant
    Filed: December 18, 2019
    Date of Patent: November 8, 2022
    Assignee: InCube Labs, LLC
    Inventors: Mir Imran, Ben Tranchina
  • Patent number: 11490840
    Abstract: A blood sequestration device configured to isolate an initial, potentially contaminated portion of blood from the flow of blood of a patient, prior to directing the flow of blood to an outlet port where the blood can be accessed. The blood sequestration device including a body member having an interior wall defining a fluid conduit having a distal portion, a first proximal portion, and a second proximal portion, wherein the first proximal portion defines a sequestration chamber configured to isolate an initial portion of blood of a flow of blood, a vent path configured to enable the escape of gas initially trapped within the sequestration chamber.
    Type: Grant
    Filed: June 25, 2019
    Date of Patent: November 8, 2022
    Assignee: Smiths Medical ASD, Inc.
    Inventors: Jay T. Breindel, Harsh D. Chheda
  • Patent number: 11484227
    Abstract: A method of in vivo conditioning of an indwelling sensor to reduce run-in time, (stabilization time) comprising: a) applying a first potential to the sensor and measuring a first current at the first potential; b) applying a second potential to the sensor and measuring a second current at the second potential; c) determining a relationship of the first current measured to the second current measured; repeating a, b, and c until the relationship between the first current measured and the second current measured has stabilized, thereby reducing sensor run-in time.
    Type: Grant
    Filed: November 1, 2018
    Date of Patent: November 1, 2022
    Assignee: WAVEFORM TECHNOLOGIES, INC.
    Inventors: Mihailo V. Rebec, Robert Bruce, Ralph Dutt-Ballerstadt
  • Patent number: 11484254
    Abstract: A joint manipulation and evaluation apparatus has a mechanism configured to manipulate a first bone of a joint relative to a second bone of the joint. The apparatus has a joint stabilizer arranged to engage the joint and hold the second bone in place as the first bone is manipulated. A sensor is coupled to the joint stabilizer and is configured and arranged to detect residual movement of a clamped portion of the joint relative to the joint stabilizer as the first bone is manipulated.
    Type: Grant
    Filed: November 20, 2016
    Date of Patent: November 1, 2022
    Assignee: RoboDiagnostics LLC
    Inventors: Thomas P. Branch, Shaun K. Stinton, Edward Dittmar, Nathaniel K. deJarnette, T. Christopher Madden
  • Patent number: 11488707
    Abstract: Automated modular physical health testing systems and associated devices and methods are disclosed herein. A modular system configured in accordance with embodiments of the present technology can include, for example, a housing, a communications hub, and a plurality of physical health testing devices. The housing integrates the communications hub and stores the plurality of physical health testing devices. The physical health testing devices are in wired and/or wireless communication with the communications hub. Each physical health testing device is configured to generate physical health data of a user and to transmit generated physical health data to the communication hub and/or a user's mobile device. The modular physical health testing system provides an automated physical exam that can be performed at user's homes or other convenient locations.
    Type: Grant
    Filed: October 30, 2020
    Date of Patent: November 1, 2022
    Assignee: Reperio Health, Inc.
    Inventors: Travis Benjamin Rush, Matthew Robert Wallington
  • Patent number: 11478156
    Abstract: An illumination source may be configured to illuminate the skin of the user. An illumination detector may detect electromagnetic radiation reflected of the skin of the user. A compensation module may be configured to determine the position of the skin of the user relative to the illumination detector. A processor may be configured to determine a heart rate of the user by analyzing information corresponding to an amount of the electromagnetic radiation detected by the illumination detector. The processor may also determine the heart rate of the user by compensating for the position of the skin of the user as determined by the compensation module.
    Type: Grant
    Filed: January 4, 2019
    Date of Patent: October 25, 2022
    Assignee: NIKE, Inc.
    Inventor: Steven H. Walker
  • Patent number: 11478184
    Abstract: A computer-implemented method and system includes accessing neurophysiological and neurovascular data recorded during sleep. A function mapping is executed from said neurophysiological and neurovascular data to a target that is one of a glymphatic flow marker, a molecular analysis marker of neurodegeneration, or a neuroimaging marker of neurodegeneration. A target prediction model is output based on the function mapping. The target prediction model can receive new neurophysiological and neurovascular data and output a predicted marker of neurodegeneration.
    Type: Grant
    Filed: April 5, 2022
    Date of Patent: October 25, 2022
    Assignee: APPLIED COGNITION, INC.
    Inventors: Paul Dagum, Gregory T. A. Kovacs, Laurent B. Giovangrandi, Carl J. Weber, Joerg C. Student, Nathan Whipple, Jonathan I. Kaplan
  • Patent number: 11471105
    Abstract: Embodiments of the present invention are directed to a two-layer adhesive and methods of using the same to secure an electronic device to an organism. In a non-limiting embodiment of the invention, a surface of the organism is coated with a first adhesive layer (bottom layer). The first adhesive layer is cured and a surface of the cured first adhesive layer is coated with a second adhesive layer (top layer). An electronic device is positioned on the second adhesive layer prior to curing the second adhesive layer. The second adhesive layer is then cured, thereby embedding the electronic device within the second adhesive layer. The bottom layer and the top layer are selected such that the bottom layer releases upon exposure to a first solvent after a first duration and the top layer releases upon exposure to a second solvent after a second duration more than the first duration.
    Type: Grant
    Filed: October 28, 2019
    Date of Patent: October 18, 2022
    Assignee: International Business Machines Corporation
    Inventors: Leanna Pancoast, Katsuyuki Sakuma
  • Patent number: 11464433
    Abstract: Embodiments provide for methods, systems, apparatus and computer readable media for calibrating an analyte sensor upon insertion into tissue of a subject based at least in part on parameters obtained from another analyte sensor already calibrated and previously inserted into the tissue of the subject. As an example, a method may include predicting a background current associated with the newly inserted sensor, subtracting the background current from a current measured by the newly inserted sensor, and converting the subtracted current to a glucose value, the converting based at least in part on the parameters obtained from the previously inserted analyte sensor. In this way, the newly inserted sensor may be calibrated without relying on actual blood-based analyte measurements, and accuracy and sensitivity of the newly inserted sensor may be improved.
    Type: Grant
    Filed: May 7, 2020
    Date of Patent: October 11, 2022
    Inventors: Mihailo V. Rebec, Ralph Dutt-Ballerstadt